---
figid: PMC9146201__ijms-23-05572-g001
pmcid: PMC9146201
image_filename: ijms-23-05572-g001.jpg
figure_link: /pmc/articles/PMC9146201/figure/ijms-23-05572-f001/
number: Figure 1
figure_title: ''
caption: Graphical representation of inhibitors of glucose transport, glycolysis pathway,
  6GPDH, and its metabolic target. GLUT—glucose transporter; HK2—hexokinase type 2;
  2-DG—2-deoxyglucose; 3-BP—3-bromopyruvate; BNBZ—benitrobenrazide; DHEA—dehydroepiandosterone;
  6-AN—6-aminonicotinamide; ZA—zoledronic acid; 6GPDH—glucose-6-phosphate dehydrogenase;
  PGI—phosphoglucose isomerase; PFK1—phosphofructokinase 1; ALDO—aldolase; TIM—triosephosphate
  isomerase; GAPDH—glyceraldehyde 3-phosphate dehydrogenase; KA—koningic acid; MG—methylglyoxal;
  PGK1—phosphoglycerate kinase 1; PGAM1—phosphoglycerate mutase 1; EGCG—epigallocatechin-3-gallate;
  ENO2—γ-enolase; PK—pyruvate kinase; LDH—lactate dehydrogenase; MCT1—monocarboxylate
  transporter 1.
article_title: Targeting Energy Metabolism in Cancer Treatment.
citation: Joanna Kubik, et al. Int J Mol Sci. 2022 May;23(10):5572.
year: '2022'

doi: 10.3390/ijms23105572
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- cancer metabolism
- cancer treatment
- glycolysis
- oxidative phosphorylation

---
